Cabaletta Bio, Inc. (CABA) vs Surrozen, Inc. (SRZN)

Cabaletta Bio, Inc. and Surrozen, Inc. are both Biotechnology companies. Cabaletta Bio, Inc. and Surrozen, Inc. are of similar size ($386.6M and $373.0M). Cabaletta Bio, Inc. has the higher net margin (0.00% vs −2,887.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Cabaletta Bio, Inc. leads on 7 and Surrozen, Inc. on 4.

Valuation

Metric CABA SRZN Biotechnology median
P/E n/m n/m 7.88
P/S n/m 29.93 11.47
P/B 1.49 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 21.07 10.73
Earnings yield (75.85%) (126.57%) (28.84%)
Free cash flow yield (49.59%) (10.15%) (23.03%)

Profitability

Metric CABA SRZN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (385.28%) 0.00%
Net margin 0.00% (2,887.07%) 0.00%
Free cash flow margin 0.00% (303.92%) 0.00%
Return on equity (93.20%) 387.44% (57.72%)
Return on assets (75.36%) (304.47%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CABA SRZN Biotechnology median
Revenue growth (TTM) — (8.79%) 5.64%
EPS growth (last fiscal year) 10.26% (49.38%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CABA SRZN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.79 12.14 4.73
Net debt to EBITDA 0.84 2.15 0.96

Dividend

Metric CABA SRZN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CABA SRZN Biotechnology median
Market cap 373.00m 386.57m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack